Associations between attainment of incentivized primary care indicators and incident lower limb amputation among those with type 2 diabetes: a population-based historical cohort study.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
04 2021
Historique:
received: 14 12 2020
revised: 18 02 2021
accepted: 03 04 2021
entrez: 27 4 2021
pubmed: 28 4 2021
medline: 22 6 2021
Statut: ppublish

Résumé

England has invested considerably in diabetes care through such programs as the Quality and Outcomes Framework (QOF) and National Diabetes Audit (NDA). Associations between program indicators and clinical endpoints, such as amputation, remain unclear. We examined associations between primary care indicators and incident lower limb amputation. This population-based retrospective cohort study, spanning 2010-2017, was comprised of adults in England with type 2 diabetes and no history of lower limb amputation. Exposures at baseline (2010-2011) were attainment of QOF glycated hemoglobin (HbA1c), blood pressure and total cholesterol indicators, and number of NDA processes completed. Propensity score matching was performed and multivariable Cox proportional hazards models, adjusting for disease-related, comorbidity, lifestyle, and sociodemographic factors, were fitted using matched samples for each exposure. 83 688 individuals from 330 English primary care practices were included. Mean follow-up was 3.9 (SD 2.0) years, and 521 (0.6%) minor or major amputations were observed (1.62 per 1000 person-years). HbA1c and cholesterol indicator attainment were associated with considerably lower risks of minor or major amputation (adjusted HRs; 95% CIs) 0.61 (0.49 to 0.74; p<0.0001) and 0.67 (0.53 to 0.86; p=0.0017), respectively). No evidence of association between blood pressure indicator attainment and amputation was observed (adjusted HR 0.88 (0.73 to 1.06; p=0.1891)). Substantially lower amputation rates were observed among those completing a greater number of NDA care processes (adjusted HRs 0.45 (0.24 to 0.83; p=0.0106), 0.67 (0.47 to 0.97; p=0.0319), and 0.38 (0.20 to 0.70; p=0.0022) for comparisons of 4-6 vs 0-3, 7-9 vs 0-3, and 7-9 vs 4-6 processes, respectively). Results for major-only amputations were similar for HbA1c and blood pressure, though cholesterol indicator attainment was non-significant. Comprehensive primary care-based secondary prevention may offer considerable protection against diabetes-related amputation. This has important implications for diabetes management and medical decision-making for patients, as well as type 2 diabetes quality improvement programs.

Identifiants

pubmed: 33903115
pii: 9/1/e002069
doi: 10.1136/bmjdrc-2020-002069
pmc: PMC8076942
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JV is National Clinical Director for Diabetes and Obesity at NHS England & Improvement.

Références

Diabetes Care. 2008 Jan;31(1):99-101
pubmed: 17934144
N Engl J Med. 2004 Sep 30;351(14):1448-54
pubmed: 15459308
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030
pubmed: 31303293
Diabetes Res Clin Pract. 1996 Apr;32(1-2):19-25
pubmed: 8803478
J Foot Ankle Surg. 2016 May-Jun;55(3):591-9
pubmed: 26898398
Diabetes Care. 2013 Nov;36(11):3591-8
pubmed: 24062322
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
J Vasc Surg. 2013 Dec;58(6):1578-1585.e1
pubmed: 23932803
Diabet Med. 2018 Jan;35(1):53-62
pubmed: 29023974
BMJ Qual Saf. 2013 Jan;22(1):53-64
pubmed: 22918988
Diabetes Care. 2018 Apr;41(4):891-898
pubmed: 29439130
Diabetes Care. 2007 Oct;30(10):2478-83
pubmed: 17623824
Diabetologia. 2015 Mar;58(3):505-18
pubmed: 25512005
Diabetes Care. 2010 Dec;33(12):2592-7
pubmed: 20833865
BMJ. 2015 Nov 11;351:h5441
pubmed: 26560308
Stat Med. 2019 Feb 28;38(5):751-777
pubmed: 30347461
Ann Vasc Surg. 2017 Jul;42:322-327
pubmed: 28389295
Diabetes Res Clin Pract. 2018 Sep;143:225-231
pubmed: 30009936
Lancet. 2005 Oct 8;366(9493):1279-89
pubmed: 16214598
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
Int J Low Extrem Wounds. 2015 Jun;14(2):168-77
pubmed: 26130760
Diabet Foot Ankle. 2015 Dec 07;6:29629
pubmed: 26651032
Lancet. 2009 May 23;373(9677):1780-8
pubmed: 19465233
Diabet Med. 1995 Sep;12(9):770-6
pubmed: 8542736
J Public Health (Oxf). 2012 Mar;34(1):138-48
pubmed: 21795302
Diabetologia. 2018 Dec;61(12):2590-2597
pubmed: 30171278
Diabetes Res Clin Pract. 2020 Jul;165:108231
pubmed: 32446799
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):534-540
pubmed: 32075418
Br J Clin Pharmacol. 2010 Jan;69(1):4-14
pubmed: 20078607
Diabetes Res Clin Pract. 2018 Jul;141:175-180
pubmed: 29777746
BMJ. 2017 Nov 16;359:j5064
pubmed: 29146579

Auteurs

Laura H Gunn (LH)

Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA laura.gunn@uncc.edu.
School of Data Science, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.
Department of Primary Care and Public Health, Imperial College London, London, UK.

Eszter P Vamos (EP)

Department of Primary Care and Public Health, Imperial College London, London, UK.

Azeem Majeed (A)

Department of Primary Care and Public Health, Imperial College London, London, UK.

Pasha Normahani (P)

Imperial Vascular Unit, Imperial College London NHS Healthcare Trust, London, UK.
Department of Surgery and Cancer, Imperial College London, London, UK.

Usman Jaffer (U)

Imperial Vascular Unit, Imperial College London NHS Healthcare Trust, London, UK.
Department of Surgery and Cancer, Imperial College London, London, UK.

German Molina (G)

Department of Primary Care and Public Health, Imperial College London, London, UK.

Jonathan Valabhji (J)

Division of Metabolism, Digestion & Reproduction, Faculty of Medicine, Imperial College London, London, UK.
Department of Diabetes and Endocrinology, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
NHS England and NHS Improvement, London, UK.

Ailsa J McKay (AJ)

Department of Primary Care and Public Health, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH